Healthcare - Biotechnology - NASDAQ - US
$ 2.9
-8.8 %
$ 5.02 M
Market Cap
-0.64
P/E
INCOME STATEMENT
0
REVENUE
-14.1 M
OPERATING INCOME
-16.9 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Exicure, Inc.
| Revenue | 0 |
| Cost Of Revenue | 920 K |
| Gross Profit | -1.42 M |
| Operating Expenses | 12.7 M |
| Operating Income | -14.1 M |
| Other Expenses | 2.84 M |
| Net Income | -16.9 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Revenue | 0 | 28.8 | (0.5) | 16.6 | 1.3 | 0.1 | 9.7 | 1.0 | 2.4 |
| GROSS PROFIT | |||||||||
| Cost Of Revenue | 0.9 | 1.9 | 1.8 | 32.1 | 19.3 | 14.1 | 13.1 | 13.7 | 10.1 |
| Gross Profit | (1.4) | 27.0 | (2.3) | (15.5) | (18.0) | (14.0) | (3.4) | (12.6) | (7.7) |
| OPERATING INCOME | |||||||||
| Operating Expenses | 12.7 | 30.7 | 62.1 | 42.0 | 27.9 | 21.9 | 20.1 | 17.2 | 15.4 |
| Selling, General and Administrative Expenses | 12.7 | 10.9 | 13.1 | 10.0 | 8.6 | 7.8 | 7.0 | 3.5 | 5.3 |
| Research and Development Expenses | 1.4 | 19.8 | 49.0 | 32.1 | 19.3 | 14.1 | 13.1 | 13.7 | 10.1 |
| Operating Income | (14.1) | (1.8) | (62.5) | (25.4) | (26.6) | (21.8) | (10.4) | (16.2) | (13.1) |
| PRE-TAX INCOME | |||||||||
| Interest Income Expense | 0 | 0.6 | 1.7 | 0.6 | 0.8 | 0.7 | 0.8 | 0.7 | 0 |
| Total Other Income | (2.8) | (0.5) | (1.6) | 0.8 | 0.3 | (0.6) | (0.6) | (0.8) | 7 K |
| Pre-Tax Income | (16.9) | (2.4) | (64.1) | (24.7) | (26.3) | (22.4) | (11.0) | (16.9) | (13.2) |
| NET INCOME | |||||||||
| Tax Provision | 0 | 0.2 | 1.7 | 0.9 | 1.2 | 0.4 | 1.0 | 0.7 | 0 |
| Net Income | (16.9) | (2.6) | (64.1) | (24.7) | (26.3) | (22.4) | (11.0) | (16.9) | (13.2) |
| EPS | 2.11 | 0.56 | 21.7 | 8.49 | 13.7 | 16.3 | 8.37 | 12.9 | 10 |